FDx Advisors Inc. boosted its stake in shares of ICON Public Limited (NASDAQ:ICLR) by 16.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 9,792 shares of the medical research company’s stock after buying an additional 1,365 shares during the period. FDx Advisors Inc.’s holdings in ICON Public were worth $1,909,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in ICLR. Todd Asset Management LLC raised its position in ICON Public by 18.6% in the fourth quarter. Todd Asset Management LLC now owns 103,487 shares of the medical research company’s stock valued at $20,177,000 after purchasing an additional 16,225 shares during the period. Kornitzer Capital Management Inc. KS raised its position in ICON Public by 1.7% in the fourth quarter. Kornitzer Capital Management Inc. KS now owns 84,766 shares of the medical research company’s stock valued at $16,528,000 after purchasing an additional 1,400 shares during the period. Fieldpoint Private Securities LLC raised its position in ICON Public by 11.4% in the fourth quarter. Fieldpoint Private Securities LLC now owns 1,237 shares of the medical research company’s stock valued at $241,000 after purchasing an additional 127 shares during the period. Sowell Financial Services LLC raised its position in ICON Public by 74.7% in the fourth quarter. Sowell Financial Services LLC now owns 255 shares of the medical research company’s stock valued at $50,000 after purchasing an additional 109 shares during the period. Finally, Captrust Financial Advisors raised its position in ICON Public by 0.8% in the third quarter. Captrust Financial Advisors now owns 25,591 shares of the medical research company’s stock valued at $5,036,000 after purchasing an additional 197 shares during the period. 81.70% of the stock is currently owned by institutional investors.

Separately, Zacks Investment Research upgraded ICON Public from a “sell” rating to a “hold” rating in a research report on Wednesday, January 13th. Eight equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $185.00.

NASDAQ:ICLR opened at $208.25 on Tuesday. The stock has a market cap of $11.17 billion, a P/E ratio of 34.71, a P/E/G ratio of 2.85 and a beta of 0.91. ICON Public Limited has a 1 year low of $104.28 and a 1 year high of $223.62. The stock has a 50-day simple moving average of $208.58 and a 200-day simple moving average of $195.65.

ICON Public Company Profile

ICON Public Limited Company, a clinical research organization, provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries in Ireland, rest of Europe, the United States, and internationally. It specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.

Further Reading: Recession

Want to see what other hedge funds are holding ICLR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICON Public Limited (NASDAQ:ICLR).

Institutional Ownership by Quarter for ICON Public (NASDAQ:ICLR)

Receive News & Ratings for ICON Public Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICON Public and related companies with MarketBeat.com's FREE daily email newsletter.